Littoral Environnement et Sociétés (LIENSs), UMR 7266, CNRS-Université de La Rochelle, 2 Rue Olympe de Gouges, 17042, La Rochelle Cedex 01, France. tamas.malkocs@gmail.com.
Pál Juhász-Nagy Doctoral School of Biology and Environmental Sciences, University of Debrecen, Egyetem tér 1, 4032, Debrecen, Hungary. tamas.malkocs@gmail.com.
Institute of Biology and Ecology, University of Debrecen, Egyetem tér 1, 4032, Debrecen, Hungary. tamas.malkocs@gmail.com.
Institute of Aquatic Ecology, Centre for Ecological Research, 4026, Debrecen, Hungary. tamas.malkocs@gmail.com.
Ctedra Diversidad Animal I and Laboratorio de Virologa y Gentica Molecular; Facultad de Ciencias Naturales y Ciencias de la Salud; Universidad Nacional de la Patagonia San Juan Bosco; 9 de Julio y Belgrano s/n; 9100 Trelew; Chubut; ARGENTINA. jgloreley@gmail.com.
Museo Argentino de Ciencias Naturales Bernardino Rivadavia; Av. ngel Gallardo 470; C1405DJR Ciudad Autnoma de Buenos Aires; ARGENTINA. gpastorino@macn.gov.ar.
Department of Evolution, Ecology, and Organismal Biology, Iowa State University, 2200 Osborn Dr, 251 Bessey Hall, Ames, IA 50011, USA. Electronic address: gsmedley@iastate.edu.
Department of Zoology, University of São Paulo, Rua do Matão, Travessa 14, n. 101, 05508-090 São Paulo, SP, Brazil. Electronic address: jorgeaudino@ib.usp.br.
Department of Evolution, Ecology, and Organismal Biology, Iowa State University, 2200 Osborn Dr, 251 Bessey Hall, Ames, IA 50011, USA. Electronic address: courtney.grula@ndsu.edu.
Department of Evolution, Ecology, and Organismal Biology, Iowa State University, 2200 Osborn Dr, 251 Bessey Hall, Ames, IA 50011, USA. Electronic address: aporathk@umn.edu.
Department of Evolution, Ecology, and Organismal Biology, Iowa State University, 2200 Osborn Dr, 251 Bessey Hall, Ames, IA 50011, USA. Electronic address: apairett@iastate.edu.
Department of Evolution, Ecology, and Organismal Biology, Iowa State University, 2200 Osborn Dr, 251 Bessey Hall, Ames, IA 50011, USA. Electronic address: aalejand@whittier.edu.
Faculty of Science, Health, Education, and Engineering, University of the Sunshine Coast, Maroochydore DC, Queensland 4558, Australia. Electronic address: felicity.masters@research.usc.edu.au.
Faculty of Science, Health, Education, and Engineering, University of the Sunshine Coast, Maroochydore DC, Queensland 4558, Australia. Electronic address: pduncan@usc.edu.au.
Department of Invertebrate Zoology, National Museum of National History, Smithsonian Institution, 10th and Constitution Ave NW, Washington, DC 20560, USA. Electronic address: StrongE@si.edu.
Department of Evolution, Ecology, and Organismal Biology, Iowa State University, 2200 Osborn Dr, 251 Bessey Hall, Ames, IA 50011, USA. Electronic address: serb@iastate.edu.
To review the current literature on the multiple types and uses of progestins in reproductive healthcare....
Progestins for contraceptive use are available in multiple forms, with the ongoing development of transdermal, intravaginal, and male contraception formulations. Noncontraceptive use of progestins oft...
Progestins have multiple uses in reproductive healthcare, including contraception, menstrual suppression, endometrial protection, and hormonal replacement therapy. The development of progestins for th...
Numerous studies have confirmed a strong association between progestins and meningiomas and the regression and/or stabilization of meningiomas after discontinuation of treatment. Osteomeningiomas repr...
Thirty-six patients (mean age 49.5 years) who presented with at least one progestin-related osteomeningioma (48 tumors total) were identified from a prospectively collected database of patients and ha...
For half of the 36 patients, treatment was prescribed for signs of hyperandrogenism, such as hirsutism, alopecia, or acne. Most lesions were spheno-orbital (35.4%) or frontal (31.2%). Although the tis...
These results show that while the soft intracranial part of progestin-related osteomeningioma tumor is the most likely to regress after treatment discontinuation, the bony part is more likely to incre...
To estimate trends in use and outcomes of progestin therapy for premenopausal patients with endometrial intraepithelial neoplasia....
The MarketScan Database was used to identify patients aged 18-50 years with endometrial intraepithelial neoplasia from 2008 to 2020. Primary treatment was classified as hysterectomy or progestin-based...
A total of 3,947 patients were identified. Hysterectomy was performed in 2,149 (54.4%); progestins were used in 1,798 (45.6%). Use of progestins increased from 44.2% in 2008 to 63.4% in 2020 ( P =.002...
The rate of conservative treatment with progestins in premenopausal individuals with endometrial intraepithelial neoplasia has increased over time, and among progestin users, progestin-releasing IUD u...
Although several studies suggest beneficial effects of low-dose estrogen-progestins (LEPs) and progestins on dysmenorrhea in Japanese women, the difference in efficacy between drugs remains unknown....
We identified studies by searching the MEDLINE, Cochrane Library, and ICHUSHI databases and included randomized controlled trials (RCTs) that used total dysmenorrhea score and visual analogue scale (V...
We identified 10 articles on eight RCTs and included seven drugs (six LEPs and one progestin, i.e., dienogest) and placebo in the analysis. Meta-analysis showed improvements in total dysmenorrhea scor...
We confirmed that LEPs and dienogest are effective for primary and secondary dysmenorrhea and suggest that continuous regimens may be more effective than cyclic regimens in improving outcomes....
Progestin based therapy is the preferred option for fertility-sparing treatment of reproductive-age women with preserved fertility in endometrial hyperplasia (EH) or early endometrial cancer (EEC). Ou...
We conducted a meta-analysis of randomized or non-randomized controlled trials by searching of PubMed, Embase, Web of science, and Cochrane database from inception to November 8, 2022. The results of ...
In the analysis of progestin administered systemically or locally, complete response (CR) was significantly higher in progestin plus metformin versus progestin alone in the EH group (pooled OR 2.08, 9...
For fertility-sparing management, compared to progestin alone, the outcomes of patients with endometrial hyperplasia and early endometrial cancer were more improved with progestin plus metformin becau...
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the effectiveness, safety, and side effects associated with the usage of different treatments for un...
Gestodene (GES), altrenogest (ALT), and medroxyprogesterone acetate (MPA) are three potent synthetic progestins detected in agricultural soils; however, their biotransformation outcomes in soils remai...
Endometriosis is a complex chronic disease that affects approximately 10% of women of reproductive age worldwide and commonly presents with pelvic pain and infertility....
A systematic review of the literature was carried out using the databases Pubmed, Scopus, Cochrane and ClinicalTrials.gov in women with a confirmed laparoscopic diagnosis of endometriosis receiving pr...
Eighteen studies were included in the meta-analysis. Progestins improved painful symptoms compared to placebo (SMD = -0.61, 95% CI (-0.77, -0.45), P < 0.00001) with no comparable differences between t...
The meta-analysis revealed that pain improvement significantly increased with the use of progestins with low adverse effects....
PROSPERO CRD42021285026....
Altrenogest (ALT), drospirenone (DRO), and melengestrol acetate (MLA) are three highly potent synthetic progestins that can be released into agricultural soils, while their fate in soil minerals remai...
Synthetic progestins are micropollutants of special concern, due to their growing use in human and veterinary therapies and their risks to aquatic life. Currently, there is a lack of environmental inf...
